APGE
Apogee Therapeutics, Inc. SEC filings
Every EDGAR filing for Apogee Therapeutics, Inc. (APGE), newest first, with AI summaries and stories.
- Ticker
- APGE
- CIK
- 1974640
- Latest filing
- Sep 14
Filings
15-12GApogee Therapeutics, Inc.APGELIVE SCHEDULE 13D/AApogee Therapeutics, Inc.APGELIVE Ownership stake disclosure by Venrock Healthcare Capital Partners III, L.P. (amended)
Venrock Healthcare Capital Partners III, L.P., filed by
SCHEDULE 13D/AApogee Therapeutics, Inc.APGELIVE Ownership stake disclosure by Fairmount Funds Management LLC (amended)
Fairmount Funds Management LLC, filed by
4Apogee Therapeutics, Inc.APGELIVE 9 insider filings
Peter Evan Harwin, insider filing for APGE
Show all 9
- 4Insider filing for APGE
- 4Insider filing for APGE
- 4Insider filing for APGE
- 4Insider filing for APGE
- 4Insider filing for APGE
- 4Insider filing for APGE
- 4Insider filing for APGE
- 4Insider filing for APGE
- 4Insider filing for APGE
Peter Evan Harwin, reporting · Fairmount Healthcare Fund II L.P., reporting · +2 more
S-8 POSApogee Therapeutics, Inc.APGELIVE S-8 POSApogee Therapeutics, Inc.APGELIVE S-8 POSApogee Therapeutics, Inc.APGELIVE S-8 POSApogee Therapeutics, Inc.APGELIVE S-8 POSApogee Therapeutics, Inc.APGELIVE POSASRApogee Therapeutics, Inc.APGELIVE 25-NSEApogee Therapeutics, Inc.APGELIVE Nasdaq Stock Market LLC, filed by
8-KApogee Therapeutics, Inc.APGELIVE 4Apogee Therapeutics, Inc.APGELIVE Peter Evan Harwin, insider filing for APGE
Peter Evan Harwin, reporting · Fairmount Healthcare Fund II L.P., reporting · +2 more
8-KApogee Therapeutics, Inc.APGELIVE 10-QApogee Therapeutics, Inc.APGELIVE 8-KApogee Therapeutics, Inc.APGELIVE 4Apogee Therapeutics, Inc.APGELIVE Carl Dambkowski, insider filing for APGE
Carl Dambkowski, reporting
DEFA14AApogee Therapeutics, Inc.APGELIVE DEFA14AApogee Therapeutics, Inc.APGELIVE 4Apogee Therapeutics, Inc.APGELIVE Jane Henderson, insider filing for APGE
Jane Henderson, reporting
4Apogee Therapeutics, Inc.APGELIVE Carl Dambkowski, insider filing for APGE
Carl Dambkowski, reporting
DEFM14AApogee Therapeutics, Inc.APGELIVE 4Apogee Therapeutics, Inc.APGELIVE Michael Thomas Henderson, insider filing for APGE
Michael Thomas Henderson, reporting
SCHEDULE 13G/AApogee Therapeutics, Inc.APGELIVE Ownership stake disclosure by WELLINGTON MANAGEMENT GROUP LLP (amended)
WELLINGTON MANAGEMENT GROUP LLP, filed by
SCHEDULE 13G/AApogee Therapeutics, Inc.APGELIVE Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)
T. Rowe Price Investment Management, Inc., filed by
SCHEDULE 13G/AApogee Therapeutics, Inc.APGELIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
4Apogee Therapeutics, Inc.APGELIVE Carl Dambkowski, insider filing for APGE
Carl Dambkowski, reporting
PREM14AApogee Therapeutics, Inc.APGELIVE 144Apogee Therapeutics, Inc.APGELIVE Carl Dambkowski, planned sale of APGE shares
Carl Dambkowski, reporting
DEFA14AApogee Therapeutics, Inc.APGELIVE 4Apogee Therapeutics, Inc.APGELIVE 2 insider filings
Carl Dambkowski, insider filing for APGE
Show all 2
- 4Insider filing for APGE
- 4Insider filing for APGE
Carl Dambkowski, reporting
SCHEDULE 13D/AApogee Therapeutics, Inc.APGELIVE Ownership stake disclosure by Fairmount Funds Management LLC (amended)
Fairmount Funds Management LLC, filed by
DEFA14AApogee Therapeutics, Inc.APGELIVE 144Apogee Therapeutics, Inc.APGELIVE Carl Dambkowski, planned sale of APGE shares
Carl Dambkowski, reporting
144Apogee Therapeutics, Inc.APGELIVE Michael Thomas Henderson, planned sale of APGE shares
Michael Thomas Henderson, reporting
DEFA14AApogee Therapeutics, Inc.APGELIVE 8-KApogee Therapeutics, Inc.APGELIVE 8-KApogee Therapeutics, Inc.APGELIVE 4Apogee Therapeutics, Inc.APGELIVE Michael Thomas Henderson, insider filing for APGE
Michael Thomas Henderson, reporting
8-KApogee Therapeutics, Inc.APGELIVE 4Apogee Therapeutics, Inc.APGELIVE Fairmount Funds Management LLC, insider filing for APGE
Fairmount Funds Management LLC, reporting · Tomas Kiselak, reporting